Association of circulating osteocalcin with cardiovascular disease and intermediate cardiovascular phenotypes: systematic review and meta-analysis

References

• Roth GA, Johnson C, Abajobir A, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25.
   PubMed Web of Science ®Google Scholar
• Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011; [cited 23 Jan 2018]. Available from: http://www.who.int/nmh/publications/ncd_report_full_en.pdf.
   Google Scholar
• Wood D. Established and emerging cardiovascular risk factors. Am Heart J. 2001;141:S49–S57.
   PubMed Web of Science ®Google Scholar
• Price PA. Gla-containing proteins of bone. Connect Tissue Res. 1989;21:51–57.
   PubMed Web of Science ®Google Scholar
• Gerdhem P, Isaksson A, Akesson K, et al. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int. 2005;16:1506–1512.
   PubMed Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–469.
   PubMed Web of Science ®Google Scholar
• Hauschka PV, Lian JB, Cole DE, et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev. 1989;69:990–1047.
   PubMed Web of Science ®Google Scholar
• Villafan BJ, Sanchez ES, Munoz-Valle JF. Molecular modulation of osteocalcin and its relevance in diabetes (Review). Int J Mol Med. 2011;28:283–293.
   PubMed Web of Science ®Google Scholar
• Starup-Linde J, Eriksen SA, Lykkeboe S, et al. Biochemical markers of bone turnover in diabetes patients–a meta-analysis, and a methodological study on the effects of glucose on bone markers. Osteoporos Int. 2014;25:1697–1708.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Laukkanen JA. Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence. Eur J Epidemiol. 2015;30:599–614.
   PubMed Web of Science ®Google Scholar
• Kim KJ, Kim KM, Park KH, et al. Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin. Calcif Tissue Int. 2012;91:370–378.
   PubMed Web of Science ®Google Scholar
• Sheng L, Cao W, Cha B, et al. Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2013;12:22.
   PubMed Web of Science ®Google Scholar
• Yang R, Ma X, Dou J, et al. Relationship between serum osteocalcin levels and carotid intima-media thickness in Chinese postmenopausal women. Menopause. 2013;20:1194–1199.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Kang M, Cho IJ, et al. Association between the circulating total osteocalcin level and the development of cardiovascular disease in middle-aged men: a mean 8.7-year longitudinal follow-up study. J Atheroscler Thromb. 2015;22:136–143.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Proportion of undercarboxylated osteocalcin and serum P1NP predict incidence of myocardial infarction in older men. J Clin Endocrinol Metab. 2015;100:3934–3942.
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA. 2000;283:2008–2012.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011; [cited 10 Mar 2015]. Available from: www.ohri.ca/programs/clinical_epidemiology/oxford.asp. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
   PubMedGoogle Scholar
• Chêne G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol. 1996;144:610–621.
   PubMed Web of Science ®Google Scholar
• Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Abbasi A, Adler AI. Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis. Ann Epidemiol. 2014;24:809–816.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Cheung BM. Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence. J Hypertens. 2015;33:2373–2381.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Apekey TA, Hemelrijck MV, et al. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis. Int J Cancer. 2015;136:1162–1170.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Chubb SA, Flicker L, et al. Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The health in men study. Osteoporos Int. 2012;23:599–606.
   PubMed Web of Science ®Google Scholar
• Lerchbaum E, Schwetz V, Pilz S, et al. Association of bone turnover markers with mortality in men referred to coronary angiography. Osteoporos Int. 2013;24:1321–1332.
   PubMed Web of Science ®Google Scholar
• Goliasch G, Blessberger H, Azar D, et al. Markers of bone metabolism in premature myocardial infarction (</= 40 years of age). Bone. 2011;48:622–626.
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Yamaguchi T, Sugimoto T. Relationship between bone biochemical markers versus glucose/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;92:393–399.
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45–49.
   PubMed Web of Science ®Google Scholar
• Bao Y, Zhou M, Lu Z, et al. Serum levels of osteocalcin are inversely associated with the metabolic syndrome and the severity of coronary artery disease in Chinese men. Clin Endocrinol (Oxf). 2011;75:196–201.
   PubMed Web of Science ®Google Scholar
• Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Molecul Cell Endocrinol. 2009;310:21–29.
   PubMed Web of Science ®Google Scholar
• Ferron M, McKee MD, Levine RL, et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2012;50:568–575.
   PubMed Web of Science ®Google Scholar
• Hinoi E, Gao N, Jung DY, et al. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol. 2008;183:1235–1242.
   PubMed Web of Science ®Google Scholar
• Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011;54:1291–1297.
   PubMed Web of Science ®Google Scholar
• Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Curr Osteoporos Rep. 2015;13:180.
   PubMed Web of Science ®Google Scholar
• Evrard S, Delanaye P, Kamel S, et al. Vascular calcification: from pathophysiology to biomarkers. Clin Chim Acta. 2015;438:401–414.
   PubMed Web of Science ®Google Scholar
• Yamanouchi D, Takei Y, Komori K. Balanced mineralization in the arterial system: possible role of osteoclastogenesis/osteoblastogenesis in abdominal aortic aneurysm and stenotic disease. Circ J. 2012;76:2732–2737.
   PubMed Web of Science ®Google Scholar
• Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. TEM. 2008;19:161–166.
   PubMed Web of Science ®Google Scholar
• Magni P, Macchi C, Sirtori CR, et al. Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases. Clin Chem Lab Med. 2016;54:1579–1587.
   PubMed Web of Science ®Google Scholar
• Gundberg CM, Looker AC, Nieman SD, et al. Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone. 2002;31:703–708.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Kushida K, Nagano A, et al. Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay. Clin Chim Acta. 2000;294:67–76.
   PubMed Web of Science ®Google Scholar
• Gundberg CM, Nieman SD, Abrams S, et al. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab. 1998;83:3258–3266.
   PubMed Web of Science ®Google Scholar